跳到主要內容

很遺憾,我們無法支援你的瀏覽器。如果可以,請升級到新版本,或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更新版本。如果無法升級,而且需要支援,請將你的回饋寄給我們。

我們衷心感謝你對這個新體驗的回饋。告訴我們你的想法(打開新的分頁/視窗)

Elsevier
與我們共同出版

EmBiology launch

Revealing Biological Connections and Pathways with EmBiology

Watch recording!(打開新的分頁/視窗)

Researchers in biological sciences are faced with the monumental task to uncover insights from overwhelming amounts of information to identify new, more effective therapies. Intense competition demands that insights are identified quickly and confidently; researchers need to be equipped with data skills to do that. EmBiology relieves this pressure by collating critical disease data into a single place and structuring it in an interactive way. This facilitates evidence-based research decisions for successful projects that ultimately bring novel treatments to patients faster. 

EmBiology is powered by an AI-driven knowledge graph of 1.4 million entities connected by 15.7 million relationships, and 87.2 million referenced and viewable facts. It helps you:  

  • Understand disease biology with cause-and-effect relationships from published experimental results  

  • Get targeted biological relationship data, using publication, relation and concept filters, with literature references  

  • Minimize the risk of research bias by removing the reliance on known literature search terms 

Comprehensive and real-time - EmBiology is updated weekly, encompassing core journals in drug development and disease biology, data from clinicalTrial.gov(打開新的分頁/視窗) and abstracts from Pubmed. With as few as five clicks, researchers can confidently organize comprehensive information on drugs, compounds, and clinical trials enabling the development of the next potential therapeutic strategy. 

If you are working in disease biology, interested in finding new therapeutic targets, and developing new drugs, join our webinar with Dr. Sherry Winter.

Press release: Elsevier launches EmBiology to deliver the unparalleled insights into biological activities that accelerate drug discovery

Initial view in EmBiology showing upstream and downstream relationships, including effect, on diabetes mellitus. Users apply advanced filters to narrow results and can explore associated references.

Date: March 7, 2024 (Thursday)

Time: 12:30 pm IST | 3:00 pm TST/SGT | 4:00 pm KST/JST | 6:00 pm AEDT

Speaker  

Dr. Sherry Winter 

Sherry Winter is the Director of Biology and Biomedical Solutions in Life Science Solutions at Elsevier, where she oversees product development for Embase and EmBiology and works closely with customers to understand research challenges and develop effective solutions to overcome those barriers. Sherry has more than thirteen years’ experience in life science marketing and product development, and a PhD in medical genetics from the University of Toronto, Canada.